GBT440

Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest

Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic Conditions

An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease

Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects